Ultragenyx Pharmaceutical (RARE) Change in Inventory (2018 - 2026)
Ultragenyx Pharmaceutical (RARE) posted quarterly Change in Inventory of $4.0 million for Q1 2026, up 300.0% year-over-year from $1.0 million in Q1 2025, and up 2766.67% quarter-over-quarter from -$150000.0 in Q4 2025.
Ultragenyx Pharmaceutical (RARE) Change in Inventory (2018 - 2026) Analysis & Trends
Ultragenyx Pharmaceutical (RARE) has reported Change in Inventory for 9 consecutive years, with $4.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory rose 300.0% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $9.0 million (down 8.87% YoY), while the FY2025 annual figure was $6.0 million, down 45.45% from the prior year.
- Change in Inventory improved to $4.0 million in Q1 2026 per RARE's latest filing, from -$150000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $5.6 million in Q3 2025 and bottomed at -$445000.0 in Q2 2025.
- Historically, Change in Inventory has averaged $2.2 million across 5 years, with a median of $2.1 million in 2024.
- Annual changes were most pronounced in 2022 — Change in Inventory jumped 1782.98% — and 2025, when it sank 110.78%.
- Ultragenyx Pharmaceutical's Change in Inventory stood at $4.2 million in 2022, then slumped by 51.82% to $2.0 million in 2023, then grew by 11.01% to $2.2 million in 2024, then sank by 106.67% to -$150000.0 in 2025, then jumped by 2766.67% to $4.0 million in 2026.
- Business Quant data shows RARE's Change in Inventory at $4.0 million in Q1 2026, -$150000.0 in Q4 2025, and $5.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.61 Bn | 2.33 Bn | 180.00 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.00 Mn |
| Jun 30, 2026 | 3.00 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | -150,000.00 |
| Dec 31, 2025 | -150,000.00 |
| Sep 30, 2025 | 5.60 Mn |
| Sep 30, 2025 | 5.60 Mn |
| Jun 30, 2025 | -445,000.00 |
| Jun 30, 2025 | -445,000.00 |
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 4.13 Mn |
| Jun 30, 2024 | 4.13 Mn |
| Mar 31, 2024 | 2.12 Mn |
| Mar 31, 2024 | 2.12 Mn |